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I as7-61 Inhibition of Camitine S~/nthesle M O ~  
Altmations in Pmloin ~ ls  of Samoplasmic 
Reticulum CaZ*.ATPmm and ~ Related With 
Glucose UllmzaUon in Rat I/llmca~lel ~ n  
K Yoneku'a z. Y Ere ~ . T. Aoya~ ~ . S. Momomm#, T. Krmoto ~, Y Hayash~-. 
' The Second Depa,tme~ ot tertemal Medicine, b~mvemtty ot )bl~o. To*y~ 
Japa~ 2 Tag~ Pharmaceutical Co. L~ Tok~ Japan 
Background- Decrease m Ca ~" upcake of ~ re~lum (SR) and 
decrease m SR Ca ~'-&TPase (SERCA2) ptot~m and mRNA leve~s have 
been ~c- - -d  m patients wtt~ congestz~e heart fadum (CHF) d~e to various 
cafdmc d~sorclem. We Ixemousty shewed that ml'ub~bon of can'~ne s ~  
by 3 -{222- tn~ h~ruum)  ~ t e  (MET-88) protected felt ven- 
tncular (LV) systobc and d~astot¢ funclmt~ mr aLS wtttt myocar~al mfarcl~on 
(MI). In the cunent study we evaluated effects of i~'~brtmn ofcamdme s~nttm- 
sis on protein levels of SERCA2 and several enzymes related w~th gtuco~e 
ut~kzatmn. 
Meffmds: We reduced MIm rats by l~at~ng leh anterior cmscenchng coro- 
nary arlen/, and adr~n~'tered I00 moJkg/day of ME'r-88 (MET-88 group) o~ 
l~acebo (MI group) fm 20 days, Sham group underwent only cardmc ex- 
Ix)sum and rece~L~d l~acebo. We measured prote~n revels of SERCA2 and 
enzymes re=ated wlth glucose u~zat~on *  ctuo~ LV myocardml h~nates  
by Western hieing 
Results. In crude LV myocmdml honmger~te, SERCA2 protein level was 
redoced by 32% [p - 005) m MI group compared wsth Sham cjreup In 
con~asL tt t~,s m.~nt3,,n o..-:n.~.= ,.n MET-88 group. Among the enzymes 
related w~th glucose uttl~zahon. ~ jen  syntase and hexokmase decrased 
by 41% and by 29% r~.e ly  m MI (p . 0.0S). The reduc~on were 
attenuated by the MET-88 treatment. SR fracben showed quaMabvely s=r~lar 
results. 
Conclus~n: Inh~brt~on fcamdmo ~mthests attenuated epressed protorn 
level ot SERCA2. It modulated those el enzymes related wrth glucose u~- 
hzabon, which may be favorable for glucose utd~zatmn and glycogen storage 
under tschemlc ondmon 
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-~  The Prevalence of  Viable in 288 Myocardium 
Patients With Congestive Heart Failure 
M. Allen Auerbach. S. Yagoubi, S. Gambhir. 1". Simantov. M. Phelps. 
H. Scheibert, J. Czemin UCLA School of Medicine. Los Angeles. Cahfom~a. 
USA 
Background: The detection of myocardial viability is clinically impo'~ant for 
man~=~L;g patients (pLS) with congestive heart failure (CHF). E~nsive areas 
of blood flow-metabolism ismatch (MM) by PET predict tt,? recovery of 
dysfunctional myocardium following revascularization (CABG; functionally 
significant MM), while small areas ot MM are associated w~th an increased 
nsk for cardiac (*oath (progtx~tP_~lly sq~m~¢am MM) Yet, tt~ prevatenco f 
myocardml wablhty tn CHF pts remains unknown 
Metflod~: To cletermme p~tenc8  of n~/ocamtat vla~ttty chn~t Nd3 
ammonta/F.18 deowglucos 0 PET studm~ oblamed m 288 CHF pat~ms 
(mean age: 62 ~ 10 y~m; mean LVEF L~ ¢ 9%) were v ,~ analyzeO 
for l~esenco of MM ~ match (ML The myoca~gum was ~ imo t9 
PegC~i~ltS', promrna!. ~ Arcl mslal ~ Otthe amenor aeptum, ameoo~, 
nnlemlaleral, tnfefo~teral, inlenm and i ~  w=l~ Imd ~x.  The LV 
chamber sLm wa~ gra(~ ~ severely, mo0e~ty, ~ e f~ ~r 
MM was consclered "hmct~lally" s ~ m  d ~5 segmen~ (appmx 25% 
of LV,myocarckum) ant! "pmgr~tcaltV" ~tcant  it ~5 ~ were 
mvofve~ 
Resu,'~ Functcma,y s~dc, ant MM ocCtmed in 26% o! pt~ with eevemty, 
26% wi~ mocleralely, 30% w~ mk~y ~ and 23% w~h normal LV ~ze 
Pmgnost~ea!~, stg~f~ant MM oc¢~ned in 26% pts wtlh severely, 26% web 
moderately. 30% with mlk~t erda~ and 33% wire non~t LV 
Conctus~: Funclmnally and ~ l y  slg~fteant as~ounts ol 
myocardmm ~ in 26% and 26% ot urmelacte~ CHF pls refereed for 
the assessment of myo~ardml vmbdtty and fl.mchen~ improvement foflowmg 
CABG can be expected in about 25% of CHF ptL Those w~th smafle~ amounts 
of wabddy n.ght beneht progno~tcally from undergemg revasculanzatmn 
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~ ~ulad~tton  of Viable Myocaldlum Favour~bl%, 
Influences Lono ~ ~ (,t Paaents Wlm 
Severe but Nat ~ leeheml¢ Left VeHdcular 
OysfuncUo. 
P Ma~z~lo. CNR ms~u~e ot C~ca; P t~ok~,  P~-  On ~t t  of the Vm 
stu~; ~ Group Nuclear Card~Ax~ and Magne~ Resonance 
tn~,~ Eteopean Sooerv ot Cart~o~. eaty 
Background: In patients wrth vanous degrees of tschem~c left ventncular 
o~on,  httte is know about the ddterm~al effect of coronary revascular- 
tzat]on 
MeU'm~s: To thLs aim. 22B palmnLs (mean age 60 z 7 yra) with prevt. 
ous myocardial mfamlmn, documented coronary artery dmease and rnam- 
tamed wa l~ underwent coronary revasculanzatmn e~her by angmplasty or 
surgery and ~ term fofiow-u~ evatuabon. Dominance of tissue wal~lity was 
defined as a marooned Thalhum-201 uptake m more than 50% of dyss¥~w- 
gm segments at real evaluated in an anatonv, ca111-segment model. Cf Ihese 
palmers. 174 had a preoperative a n g ~  eleclmn fract~n m the range 
45-26% (Group I) and 54 showed an eiec~n fraclmn ~25% (Group 2) Two 
matched group of patents (group 3, 156 pahenLs and group 4, 62 patients) 
w~n me same elec~en f,:achon ranges and vtab~Itty/dy,4tunctton raho were 
treated medfcally The 4 groups did not differ wrth respect o known deten'nl- 
nares of post]nfarctmn prognosis: age, else'ben fractmn, number of diseas,ed 
vessels and number of dy~synerg~c segrnems at rest 
ResultS: tntraoperattve mortalrty was 5% and 3% m group 1 and 2. m- 
spectnmh/(p ns: The 48-month sunnval rates were not statistically d~ffefem 
in groups I and 3 charactenzed by an interme~ate reductmn of elect~n 
fraction On me contrary, the 4 8 ~  sunmrat rates were 9"Z'/= and 72% m 
group 2 and 4 characterized by severe o'ysft.mctmn. ,~p,~.3r~ely (p - 0.011. 
ConctusKms. In patients wdh advanced mchemic left vemncular dysfunc- 
t~on and dominance of trssue v~d~lity, coronary revasculanzabon s~mficantty 
improves k:mg-term outcome and may i ~1~-3~t a reliable altematwo to heart 
transplanfafmn In parCeLs wdh ~r 'Me d'ysfm'tc~on, ~ 1  ftlerapy and 
coronary ~ lanzat~on are assooated with s~mllar annual sunnval rates 
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~ Improved Exercise Performance and Quality of Life 
in Patlenls With Symptomatic Hypertensive Left 
Ventricular Hypertrophy by VDD Pacing: 
A Double-Blind Randomized Cross-over Triel 
O A. Kass, C-H. Chen, M Talbot. M. Nakayama. R S. Kmval. J Lima. 
Johns H,.~okrns Un~=rsity. Baler.ore MD. USA 
Backgreund Left ventncular hy1~rtrophy (LVH) w~th chmmc hy1~r?ens~on 
may lead to exerttonat intolerance and congostrvo heart latium. We tesled 
the efficacy of chronic VDD pacmg, a proposed treatment for obstru~we 
HCM. on this secondary form of LVH. 
Methods: Patients w~th LVH (NYHA-ItI. 4-m. 54, artenal pressure: 160/92) 
on chronic p and/or Ca;" .l~ocker and diuretic therapy, received VDD pacmg 
~th short AV delay to maintain continuous HV apical preescitation. All had 
concentnc LVH (19 ± 0,6 mm wall thtckness), and cavity obliteration at rest 
or w~th dobutamine or Valsalva provocation. Pacing was on or off for the first 
3 mos. then switched for the next 3 mos in a randomized ouble-blind esign. 
Exercise was stu<ied by treadmill-ergome~'. 
ResultS: Maximal O~ consumption (14.1 -- 1.0 BASE vs 16.7 ± 12 
pace-ON, p = 0.04, m O2/min~-~L O2 censumpt:cn, at anaerobic threshold 
376A JACC February 1998 
(8,2 ~ 0.7 vs 11,3 ± 0,8, p < 0,001). end exercise time (375 :t: 65 vs 571 
88 eec, p = 0.003) all Improved during pacing.ON, but not pacing,OFF 
periods, Quality cf life (QOL, Mlnresot~, Living with Heart Failure) Improved 
et 3 rags regardless of pacing mode (p < 0,01), Indicating a placebo effect, 
However, by multiple comporlsone teat, QOL differed from bosellne only 
during pacing-ON, LV dimensions and wail thlcknen did not significantly 
change, In 5 pie studied thus for after 6.mee of additional pacing, Inducible 
cavity gradients by Doppler fell from 22 to 11 mmHg, exemlse time remoined 
longer (sob • 194 see, p,~ 0,01) end QOL Improved (p., 0,02), 
Conclusions: In a randomized blinded.study, VOO pacing Improves exer- 
cise pedormonce end OOL in llymptomotle p~tlente with hypertensive LVH 
~v~ng otandard medical therapy, 
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~ Intermediate Razultl of Ptrtlel Left Ventrloulaetomy 
for  Dilated CardlomyopMhy 
R,C. Staffing, J,B, Young, I', Suds, N, Smedlm, M, Goormalzlic. 
P,M. M~Orthy, Clevelar~l Cllnl~ Follt~ffoll. Clev~lon#, OH, USA 
~ n d ;  Partial left v~ntde~lectomy (PLV) mdueea lafl ventri0uler (LV) 
volume and tn(~rea~ee je(~lion fmctl0n (EF) bql hoe bean es~loeiated with 
high short term mortollty In the U,S, end Bra¢ll, 
M~tho~: Singe May 199~ we have perfeftned PLV tn 57 pla,, 4~ M t5 
F, mean age 53 ~; 14 years, Etiology WAS', 54 dilatnd eerdiomyapelhy, 1
fomillel, t valvular, and 1 i~chamic, Pre,op the mean LV EF was 13,8 ~ 6%, 
LVID 8,1 ¢ 1,0 ca, ~ardl~c index ~,t ~ 0,8 I,mln.sq m, and peek exemtse 
oWgen ~n~umptton (MV~) 10,6 • 4,0 ml/kghnin, 84 of S7 pts were listed 
for ¢~erdiac transplant and 40,4% were UNOS Stehm l, 81,4% were NYHA 
cl~n 4 end 38,8% class 3, 
Reeutls," Mean w~lght el resected LV was 95 gm, The mltrat valve was 
repaired in 55 and replaced in 2 pts, One vear Keplen.Meter suwivet is 
82,1%, One year sundvat after eerdloe transplant in a cohort el 175 pls with 
dilated cardiomyopathy et our Instltutlun was similar (87,3% p =, 0,4), One 
~r  event Ires survival (freedom from death, mechanicel support end/or 
tmn~f~t0nt mllMIng) Is 575% MVO2, NYHA class, and LV ~F Improved 
slqnlttn~nlh/In cvo('~ lm~ ~t=rvlvem, 
C%'v'¢~us/on: PLV provided event tree survival in 58% of pts, improved 
their clinical Matt=s, and averted the need for transplant, 
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~ Partial Left Ventrleulectomy: A Casuistry of  38 Casns 
FA, Lucchese, J,D, Frets FIIho. C. Ellecher, W, Perotra. J,A. Rose, P, Levies, 
E Ldcto, R. Battsta. Hospital S~o Francisco. Santa Case do Porto A/egm. 
Brazil 
Partial Loft Vontncutoctomy (PLV) is a current surgical option in treatmg 
Retractonj Heart Failure, In order to evaluate survival, quality of life and 
changes in cardiac dynamics ~ patients were operated on from clecembor 
94 to july 97, Ntean age of 49 .~ 143 yeats old, 25 males (653%) and 
13 tamales (34,3%) were included according to the following cdtene:dilated 
cerdlomyop~thy. NYHA functional class IV, contratndleatton for heart TX and 
poor quality el life, Additional procedures were: mltral bloprosthssls. ~1 
(61,7%), tricuspid annuloplssty • 12 (31.5%), mltral repair - 6 ~5.7%) and 
CABG - 4 (1Q,8%). Associated conditions such as aldal fibrillation, tricuspid 
regu~ltafton, right stdo~l failure and mltrat regurgitation ~vere present in 
a significant number ol patients. At six months follow-up the decrease in 
cardiac dimensions, as measured in 14 consecutive patients, were consistent 
- diastolic (73.84 ± 8,25 to 65,33 ~: 5,72 with p = 0.009) and systolic (65.50 
± 8.3 to 56.83 ± 5.74 with p = 0,007), Ejection Fraction increased but did not 
reach statistical significance. Left ventricular volumes decreased immediately 
-systolic (170.9 ± 36 to 74,9 ± 30,5 with p = 0,0002) and diastolic (254.9 ± 
75,4 to 110,8 ± 43.9 with p = 0.0012), Eady and late mortality were 21.5% and 
42,1% respectively, Quality of Life and functional class Improved (78.9% in 
NYHA class IV preoperatively versus 353% at six months postoperatively). 
Conclusions: PLV results in better quality of life and survival is encouraging 
considering the graveness of this cohort. 
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~ Mltral Regurgitation Redllates the Left Ventricle 
After Partial Left Ventdcutectomy (Batiste Op'~ratlon) 
A,T. KawaguchP, L. Bocchino ~, N. Takeshila ~, P.N. Lima ~. J.L. Verde ~, 
S, Kolde r, R,J, Batiste ~. ~ Tokai University: Isobars, Japan: 2Centre Medico 
Caron, Curifiba. Brazil 
Background: It remains unclear whether effects of Batista operation are 
attributable to volume reduction or to regmnad mitral competence. 
Mefhods: Among patients undergoing Batista operation, 32 had Doppler 
echocardiography preoperatively, early (<3 months) and late after surgery 
(8 tO 14 months), These portents were divided into groups with (MR+, n :  15) 
and without early postoperative MR (MR-, n = 17) end were compared for 
ventrlculer size end performance. 
Results: Although MR+ group reduced LV and.dlastolI¢ dimensions (DO) 
similar 1o MR- group eerfy after eurgmy (eafly.DD), they had the cltmona!on 
dilated back to the preoperative level by the time of late study (Late-DD) while 
MR- group kept the dimension reduee¢l ('11861e), O~uttenu~ a~l tmve~'y 
of MR early after surgery (<3 montho) did not apPear to be related lo 
severity of pro.existing MR, (Pro.MR: moderate ~ 2 mild ~ 1, none ~= 0), 
underlying pathology (%Myop~thy), or performon~ ol mitml valvuloplaoty 
(%MVP) except for patients with pnplllluy mu~le n~on follow~l by n~lral 
volvo reploeement (%MVR), who had better p~foporetNe miltal ~ 'ompe l~ 
but poorer sue,'lvel, 
MR* 7~,,0 04,0 ?5,0 0~97 6,56 66.? 8.~ 
MR- 70,1 f14,~ 63 ~ 0.6~ 46.3 5~,9 3!.3 
R ~ N~ NB ., 0,05 N~ NS N,~ 005 
Confluent1: 1~otly postoperative MR, lesiduat or new, ~n~KI  to be 
playing an importont rote dic;laftng early hemodynamlcs and late outo~ in 
patients und0rgoing Botistooperation, The reSu~ suggest an aggm~ ~i, 
multanaoue approach 1o repair MR, Role ol papil!an/muscle, mltml apparah~e 
remains un(~lear end n~s  further studies 
Effects of Hypertens ion In the Lelt Ventricle 
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~ L e f t  Ventrlcular Geometry  and Function In 
Hypertensive Patients With ECG Left Venttk:ular 
Hypertrophy: The LIFE Tlriei 
R,B, Devereux, J,N Belts, B Dahtof, E, Gero'ts. M, Niemenen. J. Nielsen, 
V, Papedemetdou, For the LIFE Stu~ Group: Comell Afedcat Center. New 
York, NY, USA 
Background: Detection of LV hyper'~hy (LVH| by ECG is inexpensz~,e but 
its accuracy is controverei~ '. ~ecause ot concerns about low ECG sensri~ty 
Methods: Echocardiograpby was used to assess LV structure and function 
in 625 participants in the LIFE LLosartan I.ntervem~n For E n~nt  reductm~ 
in hypertension) study with ECG LVH (Come, voltage x duration ~= 2.,* 10 
mmx ms.(m, or SVt + V5 or V6 >38 mm~ (average 3P 172/95, 39% women. 
15% U.S., 85% European) and in comparison gro,ps oi 284 hypertenswes 
from a population sample (NY.HTN) and 413 nomml adults. 
ResultS: LIFE patients had substantially higher LV wall thickness (1.10 vs 
0,94 ve 0.78 ca), LV mass index (123 vs 94 vs 14 Otto ~'), relative watl th=ckness 
(0,43 ve 0,38 ve 0,33), end.systolic stress (136 vs 149 ve 127 kdylr~lcm ~) 
and pulse pressure/stroke volume (1.O7 vs 0.80 vs. 67 mllmmHg), and lower 
tractional shortening (0,34 vs 0,38 vs 0.36) and midwall shortening (0.15 vs 
0.17 vs 0,18) ~hen the NY.HTN and normals (all p < 0.01). Isovolumio relax- 
ation time exco, eded 100 msoc - indicatwe of impaired diastolic relaxation - 
in 72%, 
Conclusion Thus, simple ECG criteria for LVH identify hypertensive pa- 
tients with sub.qantial abnormahhes el LV structure and function as verified 
by echocardiogmphy, 
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~ Ooppler-Ecltocardlographlc Parametsrs o f  Left 
Ventdeuier Diastol ic Funct ion in Patients With Mild 
Arterial Hypertens ion 
C.M, Schannwell. F,C, Schcobel, M. Badiian, R. Marx, T.W. Jax. G. Plehn. 
M. Leschke, B.E Strauer. Clinic of Cardiology, Heinrich Heine University,. 
Dusseldorf. Germany 
Background: The high risk of morbidity and mortality for the cardiac com- 
plications relating to hypertension leads to the conclusion, that the early 
determination ot myocardial manifestation is of considerable importance in 
patients (P) with arterial hypertension. About half of the patients with arterial 
hypertension have normal ECG's and are asymptomatic. The aim of the 
study was to investigate, whether asymptomatlc P with arterial hypertension 
and normal systolic left vontricular (LV) function already show a diastolic LV 
dysfunction. 
Methods: In 23 P with arterial hypertension (age $0 ± 12 years; systolic 
blood pressure 178 i 13 mmHg; diastolic blood pressure 98 ± 6 mmHg) ana 
18 control per-sons (C), age and sex matched, the following parameters of 
